Gilead Sciences (NASDAQ:GILD) Q1 EPS $1.37 Misses $1.54 Estimate, Sales $6.35B Beat $6.33B Estimate

Gilead Sciences (NASDAQ:GILD) reported quarterly earnings of $1.37 per share which missed the analyst consensus estimate of $1.54。

The company reported quarterly sales of $6.35 billion which beat the analyst consensus estimate of $6.33 billion。